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Colorectal cancer (CRC) represents a critical health burden 
worldwide (1,2). Although patients with localized CRC have 
a 5-year survival rate of about 90%, this ratio dramatically 
drops in patients with metastatic tumors (2). Standard and 
liquid biopsy are extremely effective for the identification 
of critical genetic lesions and to study clonal evolution in 
CRC (3,4). However, only a minor fraction of oncogenic 
mutations are clinically actionable, indicating that other 
novel therapeutic strategies are urgently needed. 
The recent discovery that our genome is pervasively 
transcribed (5) opens a novel scenario in which non-
coding RNA (ncRNA) molecules can potentially play a 
pivotal role in the control of cellular homeostasis and 
transformation. Circular RNAs (circRNAs) represent a new 
class of ncRNA whose production is finely regulated during 
development and differentiation (6). CircRNAs originate 
from the non-canonical splicing of both coding and 
ncRNAs in which an upstream splice acceptor is covalently 
bound to a downstream splice donor in a process called 
back-splicing (7). While in the last decade, the role 
of microRNAs (miRNAs) in tumorigenesis has been 
extensively investigated (8), the impact of other ncRNA 
species such as circRNAs remains largely unexplored (9,10). 
Interestingly, coding and ncRNAs intertwine complex 
relationships built on base pair complementarity (11). The 
theory of competing endogenous RNAs (ceRNAs) predicts 
that any RNA molecule can potentially regulate the level of 
multiple transcripts by subtracting (or ‘sponging’) miRNAs 
from other RNAs sharing, throughout their sequence, the 
same miRNA responsive elements (MREs) (12). CircRNAs, 
and in particular the circRNA sponge for miR-7 (ciRS-7), 
epitomize the ceRNA activity (13-15). CiRS-7 originates 
from the antisense strand of the CDR1 gene and, as any 
other circRNA, it is particularly stable and resistant to 
RNA degradation (13,14). However, ciRS-7 acts as a 
very powerful RNA sponge for miR-7, since its sequence 
contains more than 70 different MREs for this miRNA 
(13,14) CiRS-7 is highly abundant in the mammalian brain 
(13,14). Accordingly, the knock out mouse model develops 
dysfunction of excitatory synaptic transmission and 
neuropsychiatric-like alterations (16). 
Intriguingly, Weng et al. have recently identified ciRS-7 
as a critical circRNA in CRC pathogenesis (17). The analysis 
of ciRS-7 expression in 153 CRC and 44 matched normal 
mucosae revealed the over-expression of this circRNA in 
tumor specimens. The authors further validated this analysis 
in a cohort of 165 cases. Notably, ciRS-7 was overexpressed 
in advanced CRC, especially in patients with T4 disease 
and more advanced stages. Moreover, high ciRS-7 
expression correlated with poor overall survival in patients. 
Since miR-7 is frequently dysregulated in cancer (18) 
and ciRS-7 acts as a potent miR-7 sponge (Figure 1A), 
the authors investigated the biological relationship 
between these two ncRNAs in CRC. In accordance with 
the ceRNA hypothesis, ectopic expression of miR-7 in 
CRC cells strongly impaired cell proliferation, migration, 
invasion and protection from apoptosis. On the other 
hand, the co-expression of ciRS-7 dramatically reduced the 
oncosuppressor potential of miR-7 both in vitro and in vivo 
(xenografts) (Figure 1B). Mechanistically, Weng et al. 
analyzed two well-established miR-7 target genes, 
EGFR and RAF1. Both genes were found downregulated 
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at the mRNA and protein level in CRC cells over-
expressing miR-7. Conversely, EGFR and RAF1 were 
not modulated when CRC cel ls  were transfected 
with miR-7 and ciRS-7 constructs, suggesting that 
c iRS-7 was  act ing as  a  potent  sponge for  miR-7 
(Figure 1A). Finally, the authors analyzed the level of miR-7, 
ciRS-7, EGFR and RAF1 in CRC specimens. Notably, the 
levels of expression of ciRS-7 and miR-7 as well as of EGFR/
RAF1 and miR-7 were found inversely correlated in CRC 
specimens, while ciRS-7 expression was found positively 
associated with EGFR and RAF1 in the same patients. 
In the last decade the improvement in deep sequencing 
technologies and bioinformatic analysis has shed light on 
the biological relevance of the so called “dark matter” of 
our genome. The work by Weng et al. highlights the impact 
of circRNAs in cancer pathogenesis. In this specific case 
ciRS-7 represents either a powerful prognostic biomarker 
or a future possible therapeutic target for advanced CRC. 
The recent discovery that circRNAs can also be 
efficiently translated (19-21) adds a novel level of 
complexity, since these peptides can potentially influence 
gene function at the post-translational level. It is now 
evident that revealing the complex relationships between 
coding and ncRNAs in normal and transformed cells 
represents the crucial step to develop novel therapeutic 
strategies and diagnostic tools for cancer treatment.
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Figure 1 ciRS-7 impacts on colorectal cancer. (A) circRNA CDR1 as/ciRS-7 is overexpressed in colorectal cancer specimens. ciRS-7 acts as 
potent ceRNA in CRC by increasing the level of EGFR and RAF1, two critical miR-7 target genes. (B) The oncogenic properties of ciRS-7 
identified by Weng et al. in CRC. MicroRNA Responsive Elements and microRNAs are indicated as circles and rectangles, respectively, on 
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